Sema4
Edit

Sema4

http://sema4.com/
Last activity: 18.06.2025
Active
Categories: Artificial IntelligenceDataHealthTechHumanLearnMediaMedTechPlatformSocialWellness
In addition to Facebook, stay connected with us via the following social media channels:

-LinkedIn: https://www.linkedin.com/company/sema4genomics
-Twitter: https://twitter.com/sema4
-Instagram: https://www.instagram.com/sema4/
Likes
24.98K
Followers
3.54K
Website visits
86.1K /mo.
Mentions
28
Location: United States, Connecticut, Stamford
Employees: 501-1000
Phone: +1 800-298-6470
Total raised: $121M
Valuation: $1.1B
Founded date: 2017

Investors 2

Funding Rounds 1

DateSeriesAmountInvestors
30.07.2020Series C$121M-

Mentions in press and media 28

DateTitleDescription
20.06.2025The Dawn of Intelligent AI Infrastructure: WEKA and Rackspace Lead the ChargeIn the fast-paced world of artificial intelligence, innovation is the lifeblood that fuels progress. Two companies, WEKA and Rackspace Technology, are at the forefront of this revolution, introducing groundbreaking solutions that promise to...
18.06.2025Rackspace Technology and Sema4.ai Launch Industry’s First Scalable Enterprise AI Agent SolutionRackspace Technology, a leading hybrid cloud and AI solutions provider, today announced a strategic alliance with enterprise AI agent innovator Sema4.ai (“Sema4”). This collaboration integrates the Foundry for AI by Rackspace (FAIR™) servic...
04.12.2024Tomorrow's Promise, Today's Roswell Park: Leaders Tackling the Biggest Priorities in Cancer Care and TreatmentFrom left to right, Candace S. Johnson, PhD, Cameron Nolan, Roswell Park nurse , and Michael Wong, MD, PhD, FRPC, Roswell Park President and CEO Candace S. Johnson, PhD, today introduced the cancer center's first Physician in Chief — and th...
16.03.2022Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor IntegrationVenture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France Glooko, a leading provider of remote patient monitoring and data management solutions for diabet...
01.02.2022Sema4 : Further Strengthens its Market Access Team with the Addition of Jerry Conway30-year industry veteran, Jerry Conway, joins Sema4 as Senior Vice President of Market Access to lead the team STAMFORD, CT - February 1, 2022 - Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, tod...
24.01.2022Sema4 : The Positives (and Negatives) of Medical TestingThe Positives (and Negatives) of Medical Testing Posted on January 24, 2022 | Jazmin Juarez In its recent article, "When They Warn of Rare Disorders, These Prenatal Tests Are Usually Wrong,"The New York Times published a discussio...
16.11.2021Sema4 : Reports Third Quarter 2021 Financial Results and Business Highlights - Form 8-KSema4 Reports Third Quarter 2021 Financial Results and Business Highlights 36% increase in test volume (excluding COVID-19 tests) compared to the same period last year 17% growth in revenue (excluding COVID-19 tests) compared to the same pe...
04.11.2021Genetic Counselor Awareness Day Q&A with Mabel ThomasGenetic Counselor Awareness Day Q&A with Mabel Thomas Posted on November 4, 2021November 3, 2021 | Arta Ademi Happy Genetic Counseling Awareness Day! In our second Q&A to mark the occasion, we chat with Mabel Thomas, a Certified Gen...
04.11.2021Mount Sinai Uses Machine Learning to Improve Postpartum Hemorrhage Risk PredictionWhat You Should Know: – Sema4, an AI-driven genomic and clinical data intelligence platform company, recently published two studies demonstrating the utility of machine learning to predict clinical outcomes for postpartum hemorrhage (PPH). ...
03.11.2021Genetic Counselor Awareness Day Q&A with Leslie AptekarGenetic Counselor Awareness Day Q&A with Leslie Aptekar Posted on November 3, 2021 | Arta Ademi It is Genetic Counselor Awareness Day on November 4th. To mark the occasion, we are featuring some of our genetic counselors at Sema4. In ou...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In